High glucose activates pituitary proopiomelanocortin gene expression: Possible role of free radical-sensitive transcription factors

Diabetes/Metabolism Research and Reviews

Volumn 23, Issue 4, 2007, Pages 317-323

  Asaba, Koichi ^a   Iwasaki, Yasumasa ^a   Asai, Masato ^b   Yoshida, Masanori ^b   Nigawara, Takeshi ^b   Kambayashi, Machiko ^a   Hashimoto, Kozo ^a  

^a KOCHI UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adrenocorticotropin; Diabetes mellitus; Hyperglycemia; Nuclear factor kappaB; Proopiomelanocortin

Indexed keywords

CORTICOTROPIN; FREE RADICAL; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROOPIOMELANOCORTIN; TEMPOL; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ELK 4;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONSENSUS SEQUENCE; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; DNA BINDING; GEL MOBILITY SHIFT ASSAY; GENE ACTIVATION; GENE EXPRESSION REGULATION; HYPERGLYCEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IN VITRO STUDY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION;

ANIMALS; ANTIOXIDANTS; BASE SEQUENCE; CELL LINE; CONSENSUS SEQUENCE; CYCLIC N-OXIDES; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; FREE RADICALS; GENE EXPRESSION; GLUCOSE; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PITUITARY GLAND; PRO-OPIOMELANOCORTIN; PROMOTER REGIONS (GENETICS); RATS; SIGNAL TRANSDUCTION; SPIN LABELS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 34249825507     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.677     Document Type: Article

References (20)

1. Roy M, Collier B, Roy A. Hypothalamic-pituitary-adrenal axis dysregulation among diabetic outpatients. Psychiatry Res 1990; 31: 31-37.
2. Roy MS, Roy A, Gallucci WT, et al. The ovine corticotropin-releasing hormone-stimulation test in type I diabetic patients and controls: suggestion of mild chronic hypercortisolism. Metabolism 1993; 42: 696-700.
3. Roy MS, Roy A, Brown S. Increased urinary-free cortisol outputs in diabetic patients. J Diabetes Complications 1998; 12: 24-27.
4. Tojo C, Takao T, Nishioka T, Numata Y, Suemaru S, Hashimoto K. Hypothalamic-pituitary-adrenal axis in WBN/Kob rats with non-insulin dependent diabetes mellitus. Endocr J 1996; 43: 233-239.
5. Schwartz MW, Strack AM, Dallman MF. Evidence that elevated plasma corticosterone levels are the cause of reduced hypothalamic corticotrophin-releasing hormone gene expression in diabetes. Regul Pept 1997; 72: 105-112.
6. Takao T, Tojo C, Nishioka T, Hashimoto K. Increased adrenocorticotropin responses to acute stress in Otsuka Long-Evans Tokushima Fatty (type 2 diabetic) rats. Brain Res 2000; 852: 110-115.
7. Nishikawa T, Edelstein D, Du XL, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000; 404: 787-790.
8. Aoki Y, Iwasaki Y, Katahira M, Oiso Y, Saito H. Regulation of the rat proopio-melanocortin gene expression in AtT-20 cells. I: effects of the common secretagogues. Endocrinology 1997; 138: 1923-1929.
9. Lavrovsky Y, Chatterjee B, Clark RA, Roy AK. Role of redox-regulated transcription factors in inflammation, aging and age-related diseases. Exp Gerontol 2000; 35: 521-532.
10. Fan H, Sun B, Gu Q, Lafond-Walker A, Cao S, Becker LC. Oxygen radicals trigger activation of NF-kappaB and AP-1 and upregulation of ICAM-1 in reperfused canine heart. Am J Physiol Heart Circ Physiol 2002; 282: H1778-H1786.
11. Loitsch SM, von Mallinckrodt C, Kippenberger S, Steinhilber D, Wagner TO, Bargon J. Reactive oxygen intermediates are involved in IL-8 production induced by hyperosmotic stress in human bronchial epithelial cells. Biochem Biophys Res Commun 2000; 276: 571-578.
12. Takeda K, Kato M, Wu J, et al. Osmotic stress-mediated activation of RET kinases involves intracellular disulfide-bonded dimer formation. Antioxid Redox Signal 2001; 3: 473-482.
13. Vermeulen L, De Wilde G, Notebaert S, Vanden Berghe W, Haegeman G. Regulation of the transcriptional activity of the nuclear factor-κB p65 subunit. Biochem Pharmacol 2002; 64: 963-970.
14. Becquet D, Guiltaumond F, Bosler O, Francois-Bellan AM. Long-term variations of AP-1 composition after CRH stimulation: consequence on POMC gene regulation. Mol Cell Endocrinol 2001; 175: 93-100.
15. Yemeni KK, Bai W, Khan BV, Medford RM, Natarajan R. Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells. Diabetes 1999; 48: 855-864.
16. Piepr GM, Riazul H. Activation of nuclear factor kappaB in cultured endothelial cells by increased glucose concentration: prevention by calphostin C. J Cardiovasc Pharmacol 1997; 30: 528-532.
17. McKay LI, Cidlowski JA. Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocr Rev 1999; 20: 435-459.
18. Makino Y, Okamoto K, Yoshikawa N, et al. Thioredoxin: a redox-regulating cellular cofactor for glucocorticoid hormone action. Cross talk between endocrine control of stress response and cellular antioxidant defense system. J Clin Invest 1996; 98: 2469-2477.
19. Okamoto K, Tanaka H, Ogawa H, et al. Redox-dependent regulation of nuclear import of the glucocorticoid receptor. J Biol Chem 1999; 274: 10363-10371.
20. Rosmond R. Stress induced disturbances of the HPA axis: a pathway to Type 2 diabetes? Med Sci Monit 2003; 9: RA35-RA39.